Decrease in breast cancer risk persists in estrogen trial follow-up - - Drug Topics
Links shared publicly online about this topic.
- 342total visits
Decrease in breast cancer risk persists in estrogen trial follow-up - - Drug Topics
drugtopics.modernmedicine.com —
Postmenopausal women who were evaluated after taking conjugated equine estrogen had neither an increased nor decreased risk of coronary heart disease, and a decrease in breast cancer risk persisted, according to a post-intervention follow-up of the Women?s Health Initiative Estrogen-Alone Trial, published in the Journal of the American Medical Association.
View full resource at drugtopics.modernmedicine.com
Tags: Heart Disease, Cancer, Breast Cancer, Drug, Women's Health, Estrogen
Most Recently Shared on April 24, 2011 at 10:16 am By:
Decrease in breast cancer risk persists in estrogen trial follow-up: Postmenopausal women who were evaluated aft... http://bit.ly/fGQRvU
Advertisement
